Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

Clinical trial NCT06905210 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06905210
Sponsor: Eurofarma Laboratorios S.A.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acne Vulgaris Acne Vulgaris on the Face

Start date: 2026-03-01
Primary completion: 2027-02-01
Enrollment: 526

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.